10x Genomics (TXG) price target increased by 12.41% to 23.75

BioPharma DiveAvalyn, in pursuit of better lung drugs, banks $300M in an IPO

10x Genomics NewsVanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan

10x Genomics Blog10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan

10x Genomics News10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - PR Newswire

10x Genomics Blog10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Yahoo Finance UK

FierceBiotechFDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death

Endpoints NewsAbbVie faces questions about Skyrizi competition from J&J

Endpoints NewsFDA, AstraZeneca prep for oncology adcomm

AgilentPCR Plate Sealer Market Leading Players Analysis - Agilent - openPR.com

10x Genomics NewsWhy 10x Genomics Stock Is Sinking Today - TipRanks

Lonza NewsLonza Capsugel donates $50,000 to Project Hope Foundation - Index-Journal